HCG25 Gene

Name HLA complex group 25 (non-protein coding)
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Pancreatic ductal adenocarcinoma (PDAC) represents one of the most aggressive human malignancies, characterized by rapid progression, early metastasis, and resistance to conventional therapies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": " In this challenging context, the HCG‑25 cell line—established from the metastatic ascitic fluid of a human pancreatic adenocarcinoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "—serves as a valuable experimental model. HCG‑25 grows as a floating cell line exhibiting a doubling time of approximately 15.6 hours and high clonogenic efficiency in soft agar; its modal chromosome number of 72 further underscores its transformed, malignant nature. Ultrastructurally, only a small subset of cells displays terminal bars, and the line is distinguished by its lack of mucin production, immunoglobulin synthesis, or phagocytic activity. Moreover, heterotransplantation of HCG‑25 cells produces tumors that histologically resemble undifferentiated carcinoma, confirming its tumorigenic potential. Overall, HCG‑25 provides a robust platform for in vitro and in vivo studies aimed at elucidating pancreatic cancer biology and testing emerging therapeutic strategies.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "N Moniaux, S Chakraborty, M Yalniz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.bjc.6604329"}], "href": "https://doi.org/10.1038/sj.bjc.6604329"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18392050"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18392050"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yi Zhong, Zheng Wang, Baojin Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0022129"}], "href": "https://doi.org/10.1371/journal.pone.0022129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21811562"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21811562"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Olga K Mirzoeva, Eric A Collisson, Peter M Schaefer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-13-0104"}], "href": "https://doi.org/10.1158/1535-7163.MCT-13-0104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23918833"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23918833"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Michael D Arensman, Phillip Nguyen, Kathleen M Kershaw, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-15-0204"}], "href": "https://doi.org/10.1158/1541-7786.MCR-15-0204"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26224368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26224368"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "T Akagi, T Kimoto "}, {"type": "b", "children": [{"type": "t", "text": "Establishment and characteristics of a human pancreatic cancer cell line (HCG-25)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Pathol Jpn (1977)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1827.1977.tb01859.x"}], "href": "https://doi.org/10.1111/j.1440-1827.1977.tb01859.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "851032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/851032"}]}]}]}
Synonyms DJ1033B10.16
NCBI Gene ID 414765
API
Download Associations
Predicted Functions View HCG25's ARCHS4 Predicted Functions.
Co-expressed Genes View HCG25's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View HCG25's ARCHS4 Predicted Functions.

Functional Associations

HCG25 has 2,016 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 12 datasets.

Click the + buttons to view associations for HCG25 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of HCG25 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of HCG25 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at HCG25 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of HCG25 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of HCG25 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing HCG25 from the GeneSigDB Published Gene Signatures dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of HCG25 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of HCG25 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of HCG25 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of HCG25 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of HCG25 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at HCG25 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.